Eli Lilly to allow more patients to apply for special access to unapproved obesity drug
admin The announcement marks a significant pivot for Eli Lilly, which had previously remained tight-lipped regarding...
Health
California Supreme Court Shields Gilead Sciences from Liability in High-Stakes HIV Drug ‘Slow-Walking’ Lawsuit.
In a landmark decision that reverberated across the pharmaceutical industry and legal circles, the California...
Sandoz Reaches $478.5 Million Settlement to Resolve Extensive Generic Drug Price-Fixing Allegations.
Sandoz has agreed to pay $478.5 million to settle allegations by dozens of states and...
We lead the Federation of State Medical Boards. Here’s what we think about licensing AI to practice medicine
The safest and most sensible answer today is that AI is not ready to be...
Senate Bipartisan Stopgap Bill Blocks Controversial White House Plan to Politicize Federal Research Grants.
The release of the text for a bipartisan government funding stopgap measure by Senate leadership...
The Looming Medicaid Cliff: Work Requirements, Medical Frailty, and the Crisis of Coverage in Nebraska and Beyond.
Starting next week, thousands of Nebraskans enrolled in Medicaid will find themselves at the edge...
Michigan Supreme Court Clears Way for Attorney General to Investigate Eli Lilly Over Insulin Pricing.
In a landmark 4-to-3 decision that carries significant implications for the pharmaceutical industry’s pricing power,...
The Strategic Imperative of Securing the U.S. Pharmaceutical Supply Chain Against Chinese Industrial Dominance.
In the complex landscape of global health and national security, a vigorous debate has emerged...
The Invisible Scourge: Why Mycetoma Remains the Most Neglected of Tropical Diseases.
When I met Tesfaye at Boru Meda General Hospital in the Amhara region of Ethiopia,...
Pharmalittle: We’re reading about an FDA panel nixing a Duchenne drug, FTC suing Hims & Hers, and more
On Wednesday, a high-stakes meeting of the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee...
